Motor carriers are encouraged to check
their safety data at http://ai.fmcsa.dot.gov/sms to see how the SMS changes may have affected their SMS results.
FRA tracks
safety data at the nation's more than 200,000 railroad crossings.
Not exact matches
Looking
at data from the US Consumer Product
Safety Commission's National Electronic Injury Surveillance System, there's a noticeable spike around Independence Day.
The measure is aimed
at European businesses, mainly in the financial and health sectors, which have been concerned over the
safety of their
data after former NSA contractor Edward Snowden revealed in 2013 a widespread U.S. surveillance program.
We then use that to build out two additional scenarios: one assuming a doubling of the current minimum wage plus factoring in the cost of fire and building
safety improvements based on
data from the Worker Rights Consortium; and another using a «living wage» figure from the East Asia labour organization Asia Floor Wage, which is considered
at the high end of labour reform demands.
Among them: the development of a National Patient
Safety System, a
data - driven, real - time tool to help pharmacists and physicians to identify patients most
at risk of misusing medications.
Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate
safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of
data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website
at www.sec.gov.
TREB's position is that offering additional information online, even historical sales
data, constitutes a violation of privacy and could put homeowners»
safety at risk, a message it plays up in its campaign.
«We have a strong
safety culture
at Finnair, and are also a very
data - driven organization, so we want to ensure we have the best possible
data in use in aircraft performance and loading calculations,» Finnair said.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or
at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs;
safety and efficacy
data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
In a March 16 research note, Andrew Fein, an analyst
at H.C. Wainwright & Co., reported that OvaScience (OVAS: NASDAQ) shifted its focus back to research and development, after interim
data from the first 20 patients in its Phase 1 trial of OvaPrime showed no signs of efficacy despite indicating
safety and tolerability.
Earlier this week, the Department of Transportation issued a 112 - page document aimed
at ensuring that those working on self - driving tech prioritize
safety and share applicable and non-proprietary
data to speed the arrival of an autonomous future.
Since tracking the
data, companies cutting their dividends had an average Dividend
Safety Score below 20
at the time of their dividend reduction announcements.
In a radical revamp of its risk assessment process, the European Food
Safety Authority (EFSA) could publish confidential
data if deemed essential to protecting public health, according to draft rules aimed
at boosting transparency and trust in science.
For intelligent and networked
data processing,
at Interpack, Minebea Intec will be presenting a new software release for statistical process controls: SPC@Enterprise 3.0 converts all measurement
data into useful information, even in the areas of foreign body detection and dynamic checkweighing, which help to ensure product quality, food
safety and productivity.
and to obtain the Material
Safety Data Sheets (boy, are those a fun read:P) so I could take a look
at what kinds of cleaning products are used in the school.
Evidently, they are taking a page out of the playbook of the Midwives Alliance of North America (MANA), the organization that represents homebirth midwives, who conducted a publicly announced collection of
safety data from 24,000 planned homebirths and now are hiding how many deaths occurred
at the hands of homebirth midwives.
To her credit, she acknowledges that Gaskin has no training of any kind, that one of her own children died
at homebirth when she refused to seek medical attention for him and that The Farm is a new age cult, but Shapiro gives Gaskin a pass on far more than
safety data.
It nevertheless concluded that the currently available
data, combined with a lack of uniform
safety standards and regulations, were «insufficient» to support a finding that soft helmets prevented head injuries such that universal support of soft helmets was «premature
at this time.»
In addition,
at this time, the Baby - Friendly Hospital Initiative has produced no
data on the
safety of newborn fasting and weight loss caused by exclusive colostrum feeding and what degree of weight loss protects a child from brain - threatening complications like hyperbilirubinemia, hypernatremic dehydration and hypoglycemia.
That book is full of misinformation, for example he cites the Johnson & Daviss study saying «any remaing doubts about the
safety of home birth were conclusively erased» by said study — which isn't even remotely true (the home birth
data from that study actually shows that neonatal mortality is 3 TIMES higher
at home):
Larry Magid, CEO and Co-Founder of ConnectSafely.org, reflects on a panel discussion on online radicalization and extremism
at the Family Online
Safety Institute's Annual Conference and the role
data encryption plays.
«The
data they shared regarding
safety reflected a higher rate of injury on the playground
at Irving than
at our other buildings,» Jasculca said.
There isn't
data confirming the
safety or lack of
safety of bed - sharing multiples, but other studies have shown that bed - sharing with other children places an infant
at higher risk of SIDS.
Plants that sell frozen beef to the National School Lunch Program violated food
safety rules
at rates higher than the industry as a whole, according to the Tribune's computer analysis of Agriculture Department
data.
While donor human milk undergoes extensive screening and testing to ensure its
safety, a first - of - its - kind study by the Connecticut Human Milk Research Center
at Connecticut Children's Medical Center, published in the Journal of Human Lactation (JHL), has found a serious lack of standardized
data among donor milk banks across North America.
Also
at 1 p.m., Families for Excellent Schools calls for an independent monitor on School
Safety in light of the NYPD's recent
data showing a 26 percent increase in weapons recovered in NYC schools, City Hall steps, Manhattan.
The on topic Q&A included redesign plans for other streets, especially Queens Boulevard, why the administration attributes the reduction in pedestrian fatalities to Vision Zero and not to regular year - to - year variances, how the administration actually knows that driving speeds are reduced, why so few street redesign projects have been done on Staten Island,
data for any changes in
safety at this E.Tremont / Silver Street intersection, why Commissioner Bratton did not attend, why there are few speeding and failure to yield tickets issued in this (45th) precinct, the negative effect of speed bumps on emergency response vehicles, plans for marking and painting of roads, whether the mayor will seek additional red light camera authorizations from the state legislature, the paucity of criminal prosecutions against drivers who kill pedestrians and an estimate of money received from speed camera tickets.
Mayor Lovely Warren has publicly stated she wouldn't send her daughter, Taylor, to the school and Commissioner Cynthia Elliot has criticized the building's
safety going back
at least five years but White says that until the
data proves it, these fears don't prove the building is actually unsafe.
And he sat impassively
at an open cabinet meeting as two of his appointees — acting health commissioner Howard Zucker and Department of Environmental Conservation commissioner Joe Martens — recommended that the state not allow natural gas hydrofracking, citing public health «red flags» and a lack of scientific
data supporting its
safety.
«Also, manipulation of the embryo
at that very sensitive time could cause more problems for the nuclear genome, which is why
safety data is critical.»
Under the current system, chemical companies perform
safety tests or farm them out to contractors, then submit
data for review
at the Environmental Protection Agency (EPA) and other agencies.
They had to come up with an idea, submit a proposal, pass a competitive peer review
at NASA, raise money, design the equipment, put it together, make sure it passed NASA's rigorous
safety precautions, and, of course, collect
data on the flight — all work for which they received no course credit.
Follow - up
data on
safety and efficacy has been assessed
at up to six years in women age 15 - 26 and the current team of investigators also looked
at data on the large cohort of young people two years ago.
Combining
data from four different databases to look
at injury occurrence and reporting in the Philadelphia Fire Department, researchers from the Firefighter Injury Research &
Safety Trends (FIRST) program of Drexel's Dornsife School of Public Health discovered that, once injuries were more accurately coded, the difference in workers» compensation costs was as much as $ 1 million for some injuries.
A new report by researchers
at RTI Health Solutions (RTI - HS) and parent company RTI International, found that although healthcare databases have allowed for greater access to real world medical
data, using databases to evaluate the
safety of medical products is complex and requires careful research consideration.
«When you look
at other areas of injury prevention, such as motor vehicle
safety, there are streams of
data,» says Fleegler.
And even when it is an option, researchers aren't always sure how to interpret
data from trials that changed protocol midstream, says James Hoffman, medication outcomes and
safety officer
at the St. Jude Children's Research Hospital in Memphis, Tennessee.
Three studies presented
at the American Epilepsy Society's 69th Annual Meeting in Philadelphia highlight emerging efficacy and
safety data of Epidiolex, a pharmaceutical liquid formulation of cannabidiol, which is currently undergoing U.S. Food and Drug Administration (FDA) authorized Phase 3 pivotal clinical trials in the United States and across the globe by GW Pharmaceuticals.
To prevent bias, researchers are blinded from trial results until it ends, but an independent board occasionally peeks
at the
data to monitor
safety and effects.
Rwanda will present
safety and efficacy
data on 50 patients
at the American Urology Association in May 2011, and a randomized, controlled trial with 150 participants, designed to compare PrePex with the conventional surgical method is currently ongoing.
The largest CBD study presented efficacy and
safety data on GW Pharmaceutical's investigational medicine, Epidiolex (cannabidiol) from open - label Expanded Access programs
at 16 sites.
The report, «Game Changers,» made possible with support from Johnson & Johnson, takes an in - depth look
at data from the U.S. Consumer Product
Safety Commission's National Electronic Injury Surveillance System (NEISS) to explore what type of injuries are sidelining young athletes.
The state has requested additional
data from manufacturers on the
safety of pyrethroids and is analyzing
at least 700 products used in households and on farms.
«Current crash
data collection forms don't have an explicit section for truck - parking - related crashes, but we can operate under the assumption that specific types of
at - fault truck crashes, such as those due to fatigue, may be the result of inadequate parking,» said the study's lead author, Salvador Hernandez, a transportation
safety and logistics researcher
at Oregon State.
The study experienced very rapid enrollment and
at the preplanned independent
data and
safety monitoring review panel, the study was stopped early only 10 months after the study commenced because it met the primary endpoint of improving progression - free survival (time to cancer relapse).
The effort comes
at a time when U.S. traffic
safety administrators report an 8.1 percent increase in traffic fatalities for the first six months of 2015, compared with 2014
data from the same period — the largest increase year over year since 1977.
A small number of federal researchers deemed essential by their agencies would still report to work, such as those involved in caring for patients
at NIH's clinical research center, sustaining animal colonies in research laboratories, or handling weather
data seen vital to public
safety.
We
at Monsanto have pledged to listen better to and engage in dialogue with concerned groups, to be more transparent in the methods we use and the
data we have about
safety, to respect the cultural and ethical concerns of others, to share our technology with developing countries, and to make sure we deliver real benefits to our customers and to the environment.
And they looked
at official
data on traffic injuries and hospital admissions to see if the scheme had any noticeable effects on personal
safety.